JW Therapeutics pre-markets Hong Kong IPO

By Jonathan Breen
20 Oct 2020

JW (Cayman) Therapeutics has launched pre-deal investor education for its Hong Kong IPO, setting the final stage of the deal ahead of launch in motion.

The Chinese biotechnology company began three days of pre-marketing on Monday, drumming up interest for its listing, according to a source familiar with the matter.

Goldman Sachs and UBS are the IPO sponsors. They are also global co-ordinators with CICC and CLSA. ICBC International, Mirae Asset Securities and ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial